Ultragenyx Pharmaceutical

-$3.78 (-5.55%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RARE and other ETFs, options, and stocks.

About RARE

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development and commercialization of novel products for the treatment of serious rare and ultra-rare genetic diseases. Its product includes Mepsevii and Crysvita.

CEO
Emil D. Kakkis
Employees
893
Headquarters
Novato, California
Founded
2010

RARE Key Statistics

Market cap
4.38B
Price-Earnings ratio
—
Dividend yield
—
Average volume
376.99K
High today
$69.36
Low today
$64.28
Open price
$68.49
Volume
412.75K
52 Week high
$175.00
52 Week low
$63.38

RARE Earnings

-$2.03
-$1.35
-$0.68
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure